Clinical Trial Update: Adenosine Cardioplegia; Improved Cardioprotection? [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating adenosine-based cardioplegia for improved cardioprotection in angina pectoris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Angina Pectoris | Phase 1, Phase 2 | Status: COMPLETED